Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 23 2017 - 8:30AM
Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a
clinical-stage biopharmaceutical company focused on developing and
commercialising innovative therapeutics for the treatment of
respiratory diseases with significant unmet medical needs,
announced today that Jan-Anders Karlsson, PhD, CEO of Verona
Pharma, is scheduled to present at the Jefferies 2017 Global
Healthcare Conference.
An audio webcast of the presentation will be
available on the Investors section of the company website,
www.veronapharma.com. A replay of the webcast will be made
available for 90 days following the presentation.
Event: Jefferies Healthcare ConferenceDate: June 8, 2017Time:
11:30 AM EDT Location: New York, NY
For further information, please
contact:
Verona Pharma plc |
|
|
|
|
|
Tel:
+44 (0)20 3283 4200 |
Jan-Anders Karlsson, Chief Executive Officer |
|
|
|
|
|
info@veronapharma.com |
|
|
|
|
|
|
|
N+1
Singer (Nominated Adviser and UK Broker) |
|
|
|
|
|
Tel:
+44 (0)20 7496 3000 |
Aubrey Powell / James White |
|
|
|
|
|
|
|
|
|
|
|
|
|
FTI
Consulting (UK Media and Investor enquiries) |
|
|
|
|
|
Tel:
+44 (0)20 3727 1000 |
Simon
Conway / Stephanie Cuthbert / Natalie Garland-Collins |
|
|
|
|
|
veronapharma@fticonsulting.com |
|
|
|
|
|
|
|
ICR,
Inc. (US Media and Investor enquiries) |
|
|
|
|
|
|
James Heins |
|
|
|
|
|
Tel:
+1 203-682-8251James.Heins@icrinc.com |
|
|
|
|
|
|
|
Stephanie Carrington |
|
|
|
|
|
Tel.
+1 646-277-1282Stephanie.Carrington@icrinc.com |
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Apr 2024 to May 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From May 2023 to May 2024